Response to Comments: MolDX: Genetic Testing for Heritable Thoracic Aortic Disease

This document (A60206) records the comment period for MolDX LCD L39944 on genetic testing for heritable thoracic aortic disease (comment period 8/29/2024–10/12/2024), with notice beginning 7/3/2025 and an effective date of 8/17/2025. It is a responses-to-comments notice and does not contain specific coverage, limitation, documentation, or frequency criteria — refer to the final LCD L39944 for actionable coverage rules.

"This document is a response-to-comments notice for MolDX LCD L39944 (Genetic Testing for Heritable Thoracic Aortic Disease) and does not include coverage criteria or claims documentation requiremen..."

Sign up to see full coverage criteria, indications, and limitations.